THE RECEPTOR FOR TISSUE PLASMINOGEN-ACTIVATOR (T-PA) IN COMPLEX WITH ITS INHIBITOR, PAI-1, ON HUMAN HEPATOCYTES

被引:31
作者
WING, LR
BENNETT, B
BOOTH, NA
机构
[1] UNIV ABERDEEN, DEPT MOLEC & CELL BIOL, ABERDEEN AB9 1FX, SCOTLAND
[2] UNIV ABERDEEN, DEPT MED & THERAPEUT, ABERDEEN AB9 1FX, SCOTLAND
来源
FEBS LETTERS | 1991年 / 278卷 / 01期
关键词
HEPATOCYTE; RECEPTOR; ENDOCYTOSIS; T-PA; PAI-1;
D O I
10.1016/0014-5793(91)80092-H
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The binding of t-PA-PAI-1 to human hepatocytes at 4-degrees-C reached a maximum at 2 h. Scatchard analysis indicated 7400 +/- 11000 high-affinity binding sites for complex per human hepatocyte, with a K(d) of 0.87 +/- 0.09 nM. Almost identical results were achieved with the human hepatoma cell line Hep G2. Binding of [I-125]t-PA-PAI-1 complex was unaffected by high concentrations of unlabelled t-PA, PAI-1, u-PA or u-PA-PAI-1 complex; only t-PA-PAI-1 complex competed for binding. Hepatocyte-bound t-PA-PAI-1 was internalized and degraded at 37-degrees-C. Thus, hepatocytes have a specific t-PA-PAI-1 receptor that participates in clearance of this complex.
引用
收藏
页码:95 / 97
页数:3
相关论文
共 20 条
  • [1] THE RECEPTOR FOR UROKINASE-PLASMINOGEN ACTIVATOR
    BLASI, F
    STOPPELLI, MP
    CUBELLIS, MV
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 1986, 32 (03) : 179 - 186
  • [2] BLASI F, 1988, Fibrinolysis, V2, P73, DOI 10.1016/0268-9499(88)90370-0
  • [3] PLASMINOGEN-ACTIVATOR INHIBITOR FROM HUMAN-ENDOTHELIAL CELLS - PURIFICATION AND PARTIAL CHARACTERIZATION
    BOOTH, NA
    MACGREGOR, IR
    HUNTER, NR
    BENNETT, B
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1987, 165 (03): : 595 - 600
  • [4] TISSUE-TYPE PLASMINOGEN-ACTIVATOR - A REVIEW OF ITS PHARMACOLOGY AND THERAPEUTIC USE AS A THROMBOLYTIC AGENT
    COLLEN, D
    LIJNEN, HR
    TODD, PA
    GOA, KL
    [J]. DRUGS, 1989, 38 (03) : 346 - 388
  • [5] EMEIS JJ, 1985, THROMB HAEMOSTASIS, V54, P661
  • [6] FUCHS HE, 1985, BLOOD, V65, P539
  • [7] HUMAN ADULT HEPATOCYTES IN PRIMARY MONOLAYER-CULTURE - MAINTENANCE OF MIXED-FUNCTION OXIDASE AND CONJUGATION PATHWAYS OF DRUG-METABOLISM
    GRANT, MH
    BURKE, MD
    HAWKSWORTH, GM
    DUTHIE, SJ
    ENGESET, J
    PETRIE, JC
    [J]. BIOCHEMICAL PHARMACOLOGY, 1987, 36 (14) : 2311 - 2316
  • [8] KORNINGER C, 1981, THROMB HAEMOSTASIS, V46, P658
  • [9] DIFFERENT RECEPTORS MEDIATE THE HEPATIC CATABOLISM OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND UROKINASE
    KRAUSE, J
    SEYDEL, W
    HEINZEL, G
    TANSWELL, P
    [J]. BIOCHEMICAL JOURNAL, 1990, 267 (03) : 647 - 652
  • [10] PHARMACOKINETIC AND DISTRIBUTION ANALYSIS OF VARIANT FORMS OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR WITH PROLONGED CLEARANCE IN RAT
    LARSEN, GR
    METZGER, M
    HENSON, K
    BLUE, Y
    HORGAN, P
    [J]. BLOOD, 1989, 73 (07) : 1842 - 1850